Evidence map›Paper›PMID 41965717›Full record

ArticleTranslational psychiatry2026

Correlation networks of blood proteins in the neuroimmunology of schizophrenia-replication and extension.

Clark D Jeffries, Chris A Bizon, John R Ford, Jean Addington, Carrie E Bearden, Kristin Cadenhead, Tyrone D Cannon, Barbara Cornblatt, Matcheri Keshavan, Daniel Mathalon and 5 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Clark D JeffriesDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. clark_jeffries@med.unc.edu.ORCID http://orcid.org/0000-0002-3044-2649
Chris A BizonRenaissance Computing Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
John R FordPerspectrix, Pittsboro, NC, USA.
Jean AddingtonDepartment of Psychiatry, University of Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0002-8298-0756
Carrie E BeardenSemel Institute for Neuroscience and Human Behavior, Departments of Psychiatry and Behavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-8516-923X
Kristin CadenheadDepartment of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
Tyrone D CannonDepartments of Psychology and Psychiatry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-5632-3154
Barbara Cornblatt
Matcheri KeshavanHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-5945-888X
Daniel MathalonDepartment of Psychiatry, University of California San Francisco, San Francisco, USA.ORCID http://orcid.org/0000-0001-6090-4974
Larry Seidman
William S StoneHarvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2932-7288
Elaine F WalkerDepartment of Psychology, Emory University, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-9798-8101
Scott W WoodsDepartment of Psychiatry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-3103-5228
Diana O PerkinsDepartment of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-9396-2206

Funding

4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH076989U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH081902U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH081928U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH081944U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH081984U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH081988U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) 5U01MH082004U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) U01MH081857
6 · The paper itself

Abstract

The Pearson sample correlation between two biomarkers across a group of individuals can sometimes be much stronger than expected by chance. In the context of psychosis risk, we previously analyzed blood plasma protein data from initial presentations as collected in the North American Prodrome Longitudinal Study 2 (NAPLS2). We found enhanced correlation between proteins SERPINE1 and TIMP1, both promoters of coagulation and inhibitors of remodeling of extracellular matrix (ECM). Participants were unaffected community controls vs. others of clinical high risk. The SERPINE1-TIMP1 correlation was consistently higher in individuals at clinical high risk for psychosis who later converted to a psychotic disorder vs. participants who were nonconverters or unaffected community controls. Here, we extend those findings using data from a larger cohort, the North American Prodrome Longitudinal Study 3 (NAPLS3). Again, the correlation between SERPINE1 and TIMP1 remained higher in psychosis high-risk converters vs. the other groups. In NAPLS3 we added an assay for PLAT (anti-coagulation plasminogen activator strongly inhibited by SERPINE1). Comparing the three NAPLS3 groups we found a decreased correlation between SERPINE1 and PLAT in converters. In summary, the increased correlation of SERPINE1 and TIMP1 in converters is consistent with restricted brain circuit remodeling and increased tendency to coagulation. Rigorous application of permutation testing yielded NAPLS2 vs. NAPLS3 consistency of SERPINE1-TIMP1 correlation patterns with empirical p-value 0.03.

Indexed as

Blood ProteinsPlasminogen Activator Inhibitor 1Psychotic DisordersSchizophreniaTissue Inhibitor of Metalloproteinase-1AdultBiomarkersFemaleHumansLongitudinal StudiesMaleBiomarkersBlood ProteinsPlasminogen Activator Inhibitor 1SERPINE1 protein, humanTIMP1 protein, humanTissue Inhibitor of Metalloproteinase-1

Identifiers

PMID41965717
PMCPMC13183914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.